ABCC3
Basic information
Region (hg38): 17:50634777-50692253
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCC3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 71 | 81 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 0 | |||||
Total | 0 | 0 | 71 | 14 | 4 |
Variants in ABCC3
This is a list of pathogenic ClinVar variants found in the ABCC3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-50634975-G-C | Likely benign (Dec 01, 2022) | |||
17-50655826-C-T | Likely benign (Jun 01, 2024) | |||
17-50655861-C-G | not specified | Uncertain significance (Jun 03, 2024) | ||
17-50655875-C-T | not specified | Uncertain significance (Jun 10, 2024) | ||
17-50655877-T-G | not specified | Uncertain significance (Jan 26, 2022) | ||
17-50655927-C-T | Likely benign (Sep 01, 2022) | |||
17-50655934-C-T | not specified | Uncertain significance (Nov 03, 2022) | ||
17-50655956-G-A | not specified | Uncertain significance (Mar 16, 2022) | ||
17-50655968-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
17-50655988-C-T | Benign (May 01, 2023) | |||
17-50655992-T-C | not specified | Uncertain significance (Nov 09, 2023) | ||
17-50656774-C-G | not specified | Uncertain significance (Dec 18, 2023) | ||
17-50656775-G-A | Benign (May 09, 2018) | |||
17-50656778-C-A | not specified | Uncertain significance (Aug 08, 2023) | ||
17-50656819-G-T | not specified | Uncertain significance (Nov 18, 2022) | ||
17-50657125-T-C | Uncertain significance (Aug 07, 2018) | |||
17-50657132-G-A | Benign (Apr 10, 2018) | |||
17-50657140-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
17-50658104-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
17-50658133-C-G | not specified | Uncertain significance (Nov 10, 2022) | ||
17-50658190-G-T | not specified | Uncertain significance (May 24, 2024) | ||
17-50658472-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
17-50659337-G-A | not specified | Uncertain significance (May 20, 2024) | ||
17-50659353-A-G | Likely benign (-) | |||
17-50659362-C-T | not specified | Uncertain significance (Apr 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABCC3 | protein_coding | protein_coding | ENST00000285238 | 31 | 57476 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.21e-26 | 0.507 | 125260 | 0 | 488 | 125748 | 0.00194 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.630 | 848 | 901 | 0.941 | 0.0000552 | 9849 |
Missense in Polyphen | 288 | 321.22 | 0.89659 | 3591 | ||
Synonymous | 1.59 | 346 | 386 | 0.897 | 0.0000239 | 3216 |
Loss of Function | 2.29 | 52 | 73.1 | 0.711 | 0.00000358 | 799 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00378 | 0.00378 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.00174 | 0.00174 |
Finnish | 0.00116 | 0.00116 |
European (Non-Finnish) | 0.00210 | 0.00209 |
Middle Eastern | 0.00174 | 0.00174 |
South Asian | 0.00232 | 0.00229 |
Other | 0.00293 | 0.00294 |
dbNSFP
Source:
- Function
- FUNCTION: May act as an inducible transporter in the biliary and intestinal excretion of organic anions. Acts as an alternative route for the export of bile acids and glucuronides from cholestatic hepatocytes (By similarity). {ECO:0000250}.;
- Pathway
- Methotrexate Pathway, Pharmacokinetics;Bile secretion - Homo sapiens (human);ABC transporters - Homo sapiens (human);Codeine and Morphine Pathway, Pharmacokinetics;Fluoropyrimidine Pathway, Pharmacokinetics;Vinka Alkaloid Pathway, Pharmacokinetics;Lamivudine Pathway, Pharmacokinetics/Pharmacodynamics;Etoposide Pathway, Pharmacokinetics/Pharmacodynamics;Vincristine Action Pathway;Vinblastine Action Pathway;Vinorelbine Action Pathway;Vindesine Action Pathway;Etoposide Action Pathway;Lamivudine Metabolism Pathway;Etoposide Metabolism Pathway;Fluoropyrimidine Activity;Codeine and Morphine Metabolism;Drug Induction of Bile Acid Pathway;Constitutive Androstane Receptor Pathway;Pregnane X Receptor pathway;Nuclear Receptors Meta-Pathway;NRF2 pathway;Nuclear Receptors in Lipid Metabolism and Toxicity;Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling;Liver steatosis AOP;multi-drug resistance factors;Metabolism of lipids;Androgen and estrogen biosynthesis and metabolism;Metabolism;Recycling of bile acids and salts;Bile acid and bile salt metabolism;Transport of small molecules;Metabolism of steroids;Bile acid biosynthesis;ABC-family proteins mediated transport
(Consensus)
Recessive Scores
- pRec
- 0.279
Intolerance Scores
- loftool
- 0.0379
- rvis_EVS
- 0.69
- rvis_percentile_EVS
- 85.21
Haploinsufficiency Scores
- pHI
- 0.115
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.407
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.581
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Abcc3
- Phenotype
- homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- bile acid and bile salt transport;canalicular bile acid transport;transmembrane transport;ATP hydrolysis coupled anion transmembrane transport
- Cellular component
- vacuolar membrane;plasma membrane;integral component of plasma membrane;membrane
- Molecular function
- ATP binding;organic anion transmembrane transporter activity;bile acid-exporting ATPase activity;ATPase activity, coupled to transmembrane movement of substances;ATPase-coupled anion transmembrane transporter activity